UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Surgically resectable nonsmall cell lung cancer: a contemporary approach

The European respiratory journal, 2024-08, Vol.64 (2), p.2400332

2024

Volltextzugriff (PDF)

Computational representation of the aponeuroses as NURBS surfaces in 3D musculoskeletal models

Computer methods and programs in biomedicine, 2007-11, Vol.88 (2), p.112-122

2007

Volltextzugriff (PDF)

Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy

Cancer research (Chicago, Ill.), 2016-10, Vol.76 (20), p.5983-5993

2016

Volltextzugriff (PDF)

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease

British journal of cancer, 2019-01, Vol.120 (2), p.196-206

2019

Volltextzugriff (PDF)

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer

EMBO molecular medicine, 2021-07, Vol.13 (7), p.e08253-n/a

2021

Volltextzugriff (PDF)

Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (23), p.6988-7000

2016

Volltextzugriff (PDF)

Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3567-3567

2023

Volltextzugriff (PDF)

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use

Journal of cellular and molecular medicine, 2010-03, Vol.14 (3), p.528-552

2010

Volltextzugriff (PDF)

Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer

Scientific reports, 2016-11, Vol.6 (1), p.36694-36694, Article 36694

2016

Volltextzugriff (PDF)

Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9886-9894

2010

Volltextzugriff (PDF)

Update on lung cancer

Canadian journal of respiratory, critical care, and sleep medicine, 2023-07, Vol.ahead-of-print (ahead-of-print), p.1-5

2023

Volltextzugriff (PDF)

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient

JCO precision oncology, 2024-08, Vol.8, p.e2400031

2024

Volltextzugriff (PDF)

A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap

PloS one, 2009-04, Vol.4 (4), p.e5108-e5108

2009

Volltextzugriff (PDF)

A compartment model of VEGF distribution in blood, healthy and diseased tissues

BMC systems biology, 2008-08, Vol.2 (1), p.77-77, Article 77

2008

Volltextzugriff (PDF)

VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model

American journal of physiology. Heart and circulatory physiology, 2010-06, Vol.298 (6), p.H2174-H2191

2010

Volltextzugriff (PDF)

The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling

PLoS computational biology, 2009-12, Vol.5 (12), p.e1000622

2009

Volltextzugriff (PDF)

Targeting the Angiopoietin-Tie2 Pathway to Inhibit Early-Stage Cancer Metastasis

Wu, Florence T.H

2017

Volltextzugriff (PDF)

Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport

Physiological genomics, 2009-06, Vol.38 (1), p.29-41

2009

Volltextzugriff (PDF)

Modeling of Growth Factor-Receptor Systems: From Molecular-Level Protein Interaction Networks to Whole-Body Compartment Models

Computer Methods Part B, 2009, Vol.467, p.461-497

2009

Volltextzugriff (PDF)

The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling

PLoS computational biology, 2009-12, Vol.5 (12)

2009

Volltextzugriff (PDF)

Chapter 18 Modeling of Growth Factor-Receptor Systems

Methods in Enzymology, 2009, Vol.467, p.461-497

2009

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(15)

Publikationsform

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Humans
(14)
Life Sciences & Biomedicine
(14)
Vascular Endothelial Growth Factor
(10)
Angiogenesis
(8)
Animals
(8)
Models, Biological
(7)
Vascular Endothelial Growth Factor A - Metabolism
(7)
Clinical Trials
(5)
Female
(5)
Mice
(5)
Oncology
(5)
Breast Cancer
(4)
Permeability
(4)
Physiology
(4)
Tumors
(4)
Vascular Endothelial Growth Factor Receptor-1 - Metabolism
(4)
Bevacizumab
(3)
Blood Vessels
(3)
Cell Line, Tumor
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Surgically resectable nonsmall cell lung cancer: a contemporary approach

Computational representation of the aponeuroses as NURBS surfaces in 3D musculoskeletal models

Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer

Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers

Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use

Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer

Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model

Update on lung cancer

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient

A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap

A compartment model of VEGF distribution in blood, healthy and diseased tissues

VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model

The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling

Targeting the Angiopoietin-Tie2 Pathway to Inhibit Early-Stage Cancer Metastasis

Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport

Modeling of Growth Factor-Receptor Systems: From Molecular-Level Protein Interaction Networks to Whole-Body Compartment Models

The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling

Chapter 18 Modeling of Growth Factor-Receptor Systems

Suchergebnisse filtern